CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award | +79,000 | 2,236,409 | ||
| 2026-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +315,000 | 315,000 | ||
| 2026-01-08 | ROSEN TERRY J Chief Executive Officer | Gift | −35,000 | 2,157,409 | ||
| 2026-01-05 | Jaen Juan C. President | Sale 10b5-1 | −29,670 | $21.34 | $633K | 924,393 |
| 2026-01-05 | Jaen Juan C. President | Sale 10b5-1 | −2,053 | $22.34 | $46K | 922,340 |
| 2026-01-05 | Jaen Juan C. President | Sale 10b5-1 | −100 | $23.20 | $2K | 922,240 |
| 2025-12-31 | Goeltz II Robert C. Chief Financial Officer | Sale 10b5-1 | −6,552 | $23.38 | $153K | 67,924 |
| 2025-12-30 | ROSEN TERRY J Chief Executive Officer | Gift | −2,400 | 2,192,409 | ||
| 2025-12-18 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −4,343 | $22.25 | $97K | 18,531 |
| 2025-12-17 | Markus Richard Chief Medical Officer | Sale 10b5-1 | −4,494 | $22.16 | $100K | 65,647 |
| 2025-12-17 | Tang Carolyn C. General Counsel | Sale 10b5-1 | −6,810 | $22.16 | $151K | 124,734 |
| 2025-12-17 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,113 | $22.16 | $47K | 22,874 |
| 2025-12-17 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −9,983 | $22.16 | $221K | 193,024 |
| 2025-12-17 | Goeltz II Robert C. Chief Financial Officer | Sale 10b5-1 | −5,960 | $22.16 | $132K | 74,476 |
| 2025-12-17 | Jaen Juan C. President | Sale 10b5-1 | −9,983 | $22.16 | $221K | 346,012 |
| 2025-12-17 | ROSEN TERRY J Chief Executive Officer | Sale 10b5-1 | −25,744 | $22.16 | $570K | 2,194,809 |
| 2025-12-16 | Ribas Antoni Director | Gift | −5,050 | 38,600 | ||
| 2025-12-16 | Markus Richard Chief Medical Officer | Sale 10b5-1 | −5,052 | $21.88 | $111K | 70,141 |
| 2025-12-16 | Tang Carolyn C. General Counsel | Sale 10b5-1 | −7,658 | $21.88 | $168K | 131,544 |
| 2025-12-16 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,376 | $21.88 | $52K | 24,987 |
Page 3 of 9 · 177 trades